Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

Rescuing the failing heart by targeted gene transfer.

Kawase Y, Ladage D, Hajjar RJ.

J Am Coll Cardiol. 2011 Mar 8;57(10):1169-80. doi: 10.1016/j.jacc.2010.11.023. Review.

2.

Sarcoplasmic reticulum and calcium cycling targeting by gene therapy.

Hulot JS, Senyei G, Hajjar RJ.

Gene Ther. 2012 Jun;19(6):596-9. doi: 10.1038/gt.2012.34. Epub 2012 May 17. Review.

PMID:
22673498
3.

Gene therapy for heart failure.

Tilemann L, Ishikawa K, Weber T, Hajjar RJ.

Circ Res. 2012 Mar 2;110(5):777-93. doi: 10.1161/CIRCRESAHA.111.252981. Review.

4.

Gene therapy in the treatment of heart failure.

Ly H, Kawase Y, Yoneyama R, Hajjar RJ.

Physiology (Bethesda). 2007 Apr;22:81-96. Review.

5.

Cardiac gene therapy with SERCA2a: from bench to bedside.

Gwathmey JK, Yerevanian AI, Hajjar RJ.

J Mol Cell Cardiol. 2011 May;50(5):803-12. doi: 10.1016/j.yjmcc.2010.11.011. Epub 2010 Nov 18. Review.

6.

Gene therapy for heart failure: where do we stand?

Naim C, Yerevanian A, Hajjar RJ.

Curr Cardiol Rep. 2013 Feb;15(2):333. doi: 10.1007/s11886-012-0333-3. Review.

7.

Targeted gene transfer in heart failure: implications for novel gene identification.

del Monte F, Kizana E, Tabchy A, Hajjar RJ.

Curr Opin Mol Ther. 2004 Aug;6(4):381-94. Review.

PMID:
15468597
8.

Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translation.

Rincon MY, VandenDriessche T, Chuah MK.

Cardiovasc Res. 2015 Oct 1;108(1):4-20. doi: 10.1093/cvr/cvv205. Epub 2015 Aug 3. Review.

9.

Advances in gene-based therapy for heart failure.

Ly HQ, Kawase Y, Hajjar RJ.

J Cardiovasc Transl Res. 2008 Jun;1(2):127-36. doi: 10.1007/s12265-008-9022-4. Epub 2008 May 29. Review.

PMID:
20559907
10.

Advances in gene therapy for heart failure.

Fish KM, Ishikawa K.

Discov Med. 2015 Apr;19(105):285-91. Review.

11.

The Current and Future Landscape of SERCA Gene Therapy for Heart Failure: A Clinical Perspective.

Hayward C, Banner NR, Morley-Smith A, Lyon AR, Harding SE.

Hum Gene Ther. 2015 May;26(5):293-304. doi: 10.1089/hum.2015.018. Review.

PMID:
25914929
12.

Gene therapy for the treatment of heart failure: promise postponed.

Hulot JS, Ishikawa K, Hajjar RJ.

Eur Heart J. 2016 Jun 1;37(21):1651-8. doi: 10.1093/eurheartj/ehw019. Epub 2016 Feb 27. Review.

13.

Gene therapy for heart failure.

Greenberg B.

J Cardiol. 2015 Sep;66(3):195-200. doi: 10.1016/j.jjcc.2015.02.006. Epub 2015 Mar 25. Review.

14.

Gene delivery approaches to heart failure treatment.

Schroder JN, Williams ML, Koch WJ.

Expert Opin Biol Ther. 2004 Sep;4(9):1413-22. Review.

PMID:
15335309
15.

Benefit of SERCA2a gene transfer to vascular endothelial and smooth muscle cells: a new aspect in therapy of cardiovascular diseases.

Lipskaia L, Hadri L, Lopez JJ, Hajjar RJ, Bobe R.

Curr Vasc Pharmacol. 2013 Jul;11(4):465-79. Review.

PMID:
23905641
16.

Targeting sarcoplasmic reticulum calcium ATPase by gene therapy.

Gwathmey JK, Yerevanian A, Hajjar RJ.

Hum Gene Ther. 2013 Nov;24(11):937-47. doi: 10.1089/hum.2013.2512. Review.

17.

Gene therapy for heart failure.

Greenberg B.

Trends Cardiovasc Med. 2017 Apr;27(3):216-222. doi: 10.1016/j.tcm.2016.11.001. Epub 2016 Nov 5. Review.

PMID:
28063800
18.

Cardiac gene therapy: from concept to reality.

Kratlian RG, Hajjar RJ.

Curr Heart Fail Rep. 2012 Mar;9(1):33-9. doi: 10.1007/s11897-011-0077-1. Review.

19.

Adenovirus gene transfer of SERCA in heart failure. A promising therapeutic approach ?

Baartscheer A.

Cardiovasc Res. 2001 Feb 1;49(2):249-52. Review. No abstract available.

PMID:
11164834
20.

Therapeutic prospects of cardiac gene transfer.

Kizana E.

Heart Lung Circ. 2007 Jun;16(3):180-4. Epub 2007 Apr 18. Review.

PMID:
17446126

Supplemental Content

Support Center